Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial.
Fink CA, Ristau J, Buchele C, Klüter S, Liermann J, Hoegen-Saßmannshausen P, Sandrini E, Lentz-Hommertgen A, Baumann L, Andratschke N, Baumgartl M, Li M, Reiner M, Corradini S, Hörner-Rieber J, Bonekamp D, Schlemmer HP, Belka C, Guckenberger M, Debus J, Koerber SA. Fink CA, et al. Among authors: ristau j. Clin Transl Radiat Oncol. 2024 Mar 25;46:100771. doi: 10.1016/j.ctro.2024.100771. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38586081 Free PMC article.
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
Fink CA, Buchele C, Baumann L, Liermann J, Hoegen P, Ristau J, Regnery S, Sandrini E, König L, Rippke C, Bonekamp D, Schlemmer HP, Debus J, Koerber SA, Klüter S, Hörner-Rieber J. Fink CA, et al. Among authors: ristau j. Front Oncol. 2024 Feb 15;14:1308406. doi: 10.3389/fonc.2024.1308406. eCollection 2024. Front Oncol. 2024. PMID: 38425342 Free PMC article.
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk.
Hoegen P, Katsigiannopulos E, Buchele C, Regnery S, Weykamp F, Sandrini E, Ristau J, Liermann J, Meixner E, Forster T, Renkamp CK, Schlüter F, Rippke C, Debus J, Klüter S, Hörner-Rieber J. Hoegen P, et al. Among authors: ristau j. Clin Transl Radiat Oncol. 2022 Dec 19;39:100567. doi: 10.1016/j.ctro.2022.100567. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36935853 Free PMC article.
A body mass index-based method for "MR-only" abdominal MR-guided adaptive radiotherapy.
Rippke C, Renkamp CK, Stahl-Arnsberger C, Miltner A, Buchele C, Hörner-Rieber J, Ristau J, Debus J, Alber M, Klüter S. Rippke C, et al. Among authors: ristau j. Z Med Phys. 2023 Feb 7:S0939-3889(22)00134-9. doi: 10.1016/j.zemedi.2022.12.001. Online ahead of print. Z Med Phys. 2023. PMID: 36759229 Free article.
Specialised nursing tasks in cancer care and their effects.
Witzke T, Stojanov A, Ristau J, Berger-Höger B, Lindhardt CL, Balzer K, Rahn AC. Witzke T, et al. Among authors: ristau j. Pflege. 2023 Feb;36(1):20-30. doi: 10.1024/1012-5302/a000927. Epub 2023 Jan 5. Pflege. 2023. PMID: 36602257 Free article.
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Katsigiannopulos E, Piskorski L, Regnery S, Hoegen P, Ristau J, Renkamp CK, Liermann J, Forster T, Lang K, König L, Rippke C, Buchele C, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: ristau j. Cancers (Basel). 2022 Dec 8;14(24):6041. doi: 10.3390/cancers14246041. Cancers (Basel). 2022. PMID: 36551527 Free PMC article.
Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation Therapy.
Koerber SA, Kroener RC, Dendl K, Kratochwil C, Fink CA, Ristau J, Winter E, Herfarth K, Hatiboglu G, Hohenfellner M, Haberkorn U, Debus J, Giesel FL. Koerber SA, et al. Among authors: ristau j. Mol Imaging Biol. 2023 Apr;25(2):375-383. doi: 10.1007/s11307-022-01766-6. Epub 2022 Aug 23. Mol Imaging Biol. 2023. PMID: 35999425 Free PMC article.
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
Regnery S, Ristau J, Weykamp F, Hoegen P, Sprengel SD, Paul KM, Buchele C, Klüter S, Rippke C, Renkamp CK, Pohl M, Meis J, Welzel T, Adeberg S, Koerber SA, Debus J, Hörner-Rieber J. Regnery S, et al. Among authors: ristau j. Radiat Oncol. 2022 May 25;17(1):102. doi: 10.1186/s13014-022-02070-x. Radiat Oncol. 2022. PMID: 35614486 Free PMC article. Clinical Trial.
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
Ristau J, Hörner-Rieber J, Buchele C, Klüter S, Jäkel C, Baumann L, Andratschke N, Garcia Schüler H, Guckenberger M, Li M, Niyazi M, Belka C, Herfarth K, Debus J, Koerber SA. Ristau J, et al. Radiat Oncol. 2022 Apr 15;17(1):75. doi: 10.1186/s13014-022-02047-w. Radiat Oncol. 2022. PMID: 35428327 Free PMC article. Clinical Trial.
35 results